Equivalence between branded enoxaparin and biosimilar enoxaparin.
deaths, death, postoperative bleeding
BSE, HEPARIN-INDUCED THROMBOCYTOPENIA, POSTOPERATIVE BLEEDING, COMPLICATION
The number of patients who developed a post-operative complication was 14 (17.3%) in the BE group and eight (9.2%) in the BSE group (p = 0.120). Two patients (2.5%) had postoperative bleeding in the BE group and one patient (1.1%) had postoperative bleeding in the BSE group (p = 0.610). No incident of heparin-induced thrombocytopenia was mentioned in BE group and one incident occurred in BSE group (p = 1.000). There were six deaths (7.4%) in the BE group and 11 deaths (12.6%) in the BSE group without statistically significant difference between the two groups (p = 0.261). The median time to death was 10 days [6.25–14.25] in the BE group and 16 days [